Imerys S.A. (NK.PA) Bundle
Investors tracking Imerys S.A. will find a mixed financial picture: FY2024 revenue stood at €3.6 billion (a 4.99% decline year-on-year) while the trailing twelve months to June 30, 2025 show revenue of €3.44 billion (down 7.71%), yet Q1 2025 delivered a modest 0.7% organic sales uptick and segment dynamics tell a different story-Performance Minerals generated €1.056 billion (about 60% of group sales), Graphite & Carbon surged 22.5% YoY driven by EV demand, and Solutions for Energy Transition rose 20% versus 2024; profitability signals include Q1 2025 adjusted EBITDA of €128 million (margin 14.7%) and FY2024 adjusted EBITDA of €675 million (+11.4% like‑for‑like, margin 18.7%), though Q1 net income slid to €31 million from €69 million last year while FY2024 net income was €196 million (+22%), and management delivered €111 million in gross cost savings (~3% of costs); balance sheet and liquidity metrics warrant scrutiny as net financial debt climbed to €1,410 million at June 30, 2025 (from €1,275 million), net debt/adjusted EBITDA rose to 2.5x (H1 2025 vs 1.9x at end‑2024), shareholders' equity fell to €3,109 million (from €3,301 million), net current free operating cash flow was €40 million in H1 2025 (versus €88 million in H1 2024), and yet rating agencies still assign investment‑grade scores (S&P BBB-, Moody's Baa3) while the company proposed a cash dividend of €1.45 per share (+7.4%); valuation and growth angles include a market cap of €1.83 billion (as of Oct 21, 2025), a €200 million green industry tax credit for the EMILI lithium project (Sept 2025), and a strategy allocating roughly 40% of capex to fast‑growing markets-read on for a detailed breakdown of how these figures translate into risk, liquidity, valuation and growth implications.}
Imerys S.A. (NK.PA) - Revenue Analysis
Imerys reported consolidated revenue of €3.60 billion for fiscal year 2024, a 4.99% decline versus FY2023. Trailing twelve months (TTM) revenue through June 30, 2025 was €3.44 billion, down 7.71% year-over-year. Q1 2025 showed a 0.7% organic sales growth, suggesting early stabilization.- FY 2024 revenue: €3.60 billion (-4.99% vs. prior year)
- TTM to 30 Jun 2025: €3.44 billion (-7.71% YoY)
- Q1 2025 organic growth: +0.7%
- Performance Minerals: €1.056 billion revenue - ~60% of group sales (largest contributor)
- Graphite & Carbon: +22.5% YoY revenue growth, driven by EV demand and conductive polymers
- Solutions for Energy Transition: +20% revenue vs. 2024, reflecting expansion in sustainable markets
| Metric | Value | YoY Change |
|---|---|---|
| Total revenue (FY 2024) | €3,600,000,000 | -4.99% |
| TTM revenue (to 30/06/2025) | €3,440,000,000 | -7.71% |
| Q1 2025 organic growth | +0.7% | - |
| Performance Minerals revenue | €1,056,000,000 | Contributes ~60% of group sales |
| Graphite & Carbon growth | - | +22.5% YoY |
| Solutions for Energy Transition growth | - | +20% vs. 2024 |
- EV and conductive polymer demand fueling Graphite & Carbon outperformance.
- Energy-transition products lifting growth in targeted segments (+20%).
- Overall group revenue down on a TTM basis; performance minerals still the backbone at ~60% share.
Imerys S.A. (NK.PA) - Profitability Metrics
Imerys' recent results show mixed signals: operational leverage and cost savings supporting margins while net income volatility reflects items below EBITDA and cyclical pressures. Key headline figures and trends are outlined below.
- Adjusted EBITDA Q1 2025: €128 million (+4% YoY), margin 14.7%.
- Adjusted EBITDA FY 2024: €675 million (+11.4% like‑for‑like), margin 18.7%.
- Net income Q1 2025: €31 million (down from €69 million in Q1 2024).
- Net income FY 2024: €196 million (+22% YoY).
- Gross cost savings achieved: €111 million (≈3% of total costs).
- Adjusted EBITDA margin trend: 16.7% in 2023, up from 16.5% in 2022.
| Period | Adjusted EBITDA (€m) | Adjusted EBITDA Margin | Net Income (€m) | YoY Change (EBITDA / Net Income) |
|---|---|---|---|---|
| Q1 2025 | 128 | 14.7% | 31 | EBITDA +4% / Net Income down from 69 to 31 |
| Q1 2024 | 123 (implied) | - | 69 | - |
| FY 2024 | 675 | 18.7% | 196 | EBITDA +11.4% LFL / Net Income +22% |
| FY 2023 | - | 16.7% | - | Margin up from 16.5% in 2022 |
Drivers behind these metrics include pricing, mix, cost transformation and one‑off items. Cost discipline is material - the company reports €111 million of gross cost savings, roughly 3% of total costs, supporting margin resilience even where net income fluctuates. For broader context on Imerys' strategy and business model, see Imerys S.A.: History, Ownership, Mission, How It Works & Makes Money.
Imerys S.A. (NK.PA) - Debt vs. Equity Structure
Imerys S.A. (NK.PA) entered H1 2025 with a higher leverage profile versus year-end 2024, driven by a rise in net financial debt and a decline in shareholders' equity. Key headline figures for investors to note:- Net financial debt: €1,410 million (June 30, 2025) vs. €1,275 million (Dec 31, 2024).
- Net financial debt / adjusted EBITDA: 2.5x (H1 2025) vs. 1.9x (Dec 31, 2024).
- Shareholders' equity: €3,109 million (H1 2025) vs. €3,301 million (Dec 31, 2024).
- Net financial debt / shareholders' equity: 45.4% (H1 2025) vs. 38.6% (Dec 31, 2024).
- Credit ratings: S&P BBB-; Moody's Baa3 (both in the Investment Grade category).
- Proposed cash dividend for 2024: €1.45 per share (up 7.4% year-over-year).
| Metric | Dec 31, 2024 | Jun 30, 2025 (H1) |
|---|---|---|
| Net financial debt (€m) | 1,275 | 1,410 |
| Adjusted EBITDA (implicit used for ratio) | - (calculated from ratio) | - (calculated from ratio) |
| Net financial debt / adjusted EBITDA (x) | 1.9 | 2.5 |
| Shareholders' equity (€m) | 3,301 | 3,109 |
| Net financial debt / shareholders' equity (%) | 38.6 | 45.4 |
| Credit ratings | S&P: BBB-; Moody's: Baa3 | S&P: BBB-; Moody's: Baa3 |
| Proposed cash dividend (€ / share) | 1.35 (2023) | 1.45 (2024) |
- Leverage trajectory: The move from 1.9x to 2.5x net debt / adjusted EBITDA signals greater reliance on debt in the short term and a reduced cushion from earnings.
- Equity pressure: A €192 million decline in shareholders' equity year-to-date increases solvency sensitivity and raises the net debt/equity ratio to 45.4%.
- Credit resilience: Despite higher leverage, Investment Grade ratings (S&P BBB-, Moody's Baa3) indicate continued access to capital markets at reasonable terms.
- Shareholder returns: A proposed €1.45 dividend shows management intent to sustain cash returns amid deleveraging needs, implying confidence in cash generation.
Imerys S.A. (NK.PA) - Liquidity and Solvency
Imerys shows a mixed short-term cash flow picture versus strong medium-term deleveraging achieved in 2023. Key cash flow and leverage datapoints for investors to note are summarized below and detailed in the table that follows.
- Net current free operating cash flow: €40m in H1 2025 (down from €88m in H1 2024).
- Full-year net current free operating cash flow: €191m in 2023 (up from €20m in 2022).
- Net debt reduction of €548m in 2023 improved net financial debt / current EBITDA to 1.8x (from 2.3x in Dec 2022).
- Net financial debt / adjusted EBITDA rose to 2.5x in H1 2025 versus 1.9x at end-2024, reflecting higher leverage in the first half of 2025.
- Overall liquidity remains supported by substantial cash flow generation and a solid financial structure.
| Metric | H1 2025 | H1 2024 | 2023 (FY) | 2022 (FY) | Dec 2022 / End-2024 (reference) |
|---|---|---|---|---|---|
| Net current free operating cash flow | €40m | €88m | €191m | €20m | - |
| Net debt reduction (2023) | €548m reduction (2023) | Improved net financial debt / current EBITDA to 1.8x (vs 2.3x Dec 2022) | |||
| Net financial debt / adjusted EBITDA | 2.5x (H1 2025) | - | 1.8x (FY 2023) | - | 2.3x (Dec 2022); 1.9x (End-2024) |
| Liquidity profile | Solid - supported by substantial cash flow generation and a conservative financial structure | ||||
- Investor implications: monitor H2 2025 cash conversion to assess whether leverage (2.5x) trends back toward the 1.9x end-2024 level.
- Operational focus: sustaining cash generation and prioritizing debt reduction will be key to restoring the lower leverage achieved after the €548m 2023 reduction.
- Where to read more: Exploring Imerys S.A. Investor Profile: Who's Buying and Why?
Imerys S.A. (NK.PA) - Valuation Analysis
Imerys' current valuation reflects a combination of recent operational improvements and near-term top-line pressure. The headline figures below set the starting point for any investor assessment:- Market capitalization: €1.83 billion (as of October 21, 2025).
- Trailing twelve months (TTM) revenue: €3.44 billion, down 7.71% YoY for the period ending June 30, 2025.
- Net financial debt / adjusted EBITDA: 2.5x in H1 2025 (up from 1.9x at end-2024).
- Adjusted EBITDA margin: 16.7% in 2023 (vs. 16.5% in 2022).
- Gross cost savings achieved: €111 million (~3% of total costs).
- Proposed cash dividend for 2024: €1.45 per share (+7.4% vs prior year).
| Metric | Value | Period / Note |
|---|---|---|
| Market capitalization | €1.83 billion | As of 21-Oct-2025 |
| Revenue (TTM) | €3.44 billion | TTM ending 30-Jun-2025, -7.71% YoY |
| Adjusted EBITDA margin | 16.7% | FY 2023 (up from 16.5% in 2022) |
| Net financial debt / Adjusted EBITDA | 2.5x | H1 2025 (1.9x at end-2024) |
| Gross cost savings | €111 million (~3% of costs) | Program savings capture |
| Dividend (proposed) | €1.45 / share | For 2024, +7.4% YoY |
- Leverage trajectory - the jump to 2.5x net debt/EBITDA suggests tighter covenant and refinancing sensitivity; monitor EBITDA recovery and debt maturities.
- Margin resilience - slight improvement in adjusted EBITDA margin to 16.7% indicates operational leverage and cost program impact despite declining revenue.
- Cash generation vs. payout - a €1.45/share dividend signals shareholder returns remain a priority; compare free cash flow after capex and debt service.
- Cost-savings durability - €111M (≈3% of costs) supports margin upside; persistence of these savings will affect forward valuation multiple.
- Top-line pressure - a 7.71% YoY revenue decline is material; recovery or stabilization is critical to justify current market cap and multiple expansion.
| Valuation measure | Imerys (reported) | Implication |
|---|---|---|
| EV / Adjusted EBITDA | Implied range dependent on EV calculation | Higher leverage and lower revenue push EV/EBITDA sensitivity; use mid-cycle EBITDA for normalized multiple. |
| Price / Earnings | Variable (earnings volatility due to cyclical end‑markets) | Earnings swings make P/E less reliable; prefer EV/EBITDA and FCF yield analysis. |
| Dividend yield | Depends on share price (€1.45 payout) | Attractive if share price low relative to peers; factor sustainability into yield assessment. |
Imerys S.A. (NK.PA) Risk Factors
Imerys faces multiple near-term and structural risks that can materially affect cash flow, profitability and valuation. Key areas of concern include demand weakness in end markets, rising leverage, currency exposure and sector-specific slowdowns.- Weak demand environment: residential construction activity remains subdued across major geographies, directly reducing volumes and pricing power for construction-related minerals.
- Revenue decline: trailing twelve months (TTM) revenue for the period ending 30 June 2025 totaled €3.44 billion, down 7.71% year-over-year, reflecting softer end-market consumption.
- Profitability pressure: reported net income in Q1 2025 was €31 million versus €69 million in Q1 2024, a significant YoY contraction.
- Higher leverage: net financial debt to adjusted EBITDA increased to 2.5x in H1 2025, indicating reduced margin for error and greater sensitivity to interest and cash-flow shocks.
- Currency exposure: a marked depreciation of the US dollar versus the euro has depressed reported dollar-denominated sales and margins after translation.
- Sector slowdowns: notable weakness in industrial and automotive demand in Europe further pressures volumes and aftermarket sales.
| Metric | Value | Period |
|---|---|---|
| TTM Revenue | €3.44 billion | ending 30 Jun 2025 |
| Revenue YoY change | -7.71% | TTM vs prior TTM |
| Net income (quarter) | €31 million | Q1 2025 |
| Net income (quarter prior year) | €69 million | Q1 2024 |
| Net financial debt / adjusted EBITDA | 2.5x | H1 2025 |
| Primary FX impact | USD depreciation vs EUR | H1 2025 |
- Liquidity and refinancing risk: elevated leverage increases the importance of available liquidity, covenant headroom and access to capital markets if cash generation weakens.
- Pricing and margin compression: weak end-market demand and adverse FX can force lower realized prices and squeeze adjusted EBITDA margins.
- Concentration and exposure: dependence on cyclical industries (construction, industrial, automotive) amplifies revenue volatility during regional slowdowns.
- Operational risks: cost inflation, energy & logistics constraints, or supply disruptions could exacerbate margin pressure when volumes fall.
Imerys S.A. (NK.PA) Growth Opportunities
Imerys S.A. (NK.PA) is positioning its portfolio and capital allocation to capture demand in higher-growth, sustainability-driven markets. Key strategic moves combine project-level investments, targeted end-market expansion, and commitments to renewable power and biodiversity that together underpin the group's mid-term organic growth targets.- EMILI lithium project in France: strategic investment supported by a €200 million green industry tax credit received in September 2025, accelerating development and de-risking near-term capex.
- Targeted end-markets: food & beverage, filtration, pharmaceuticals - areas where specialty minerals command higher margins and secular demand growth.
- Sustainability actions: first biodiversity report published and a major US power purchase agreement (PPA) signed to lower Scope 2 emissions and energy cost volatility.
- Financial targets: aiming for 3-5% organic profitable growth per year between 2023 and 2025, backed by prioritized investments.
- Capex allocation: roughly 40% of capital expenditures directed to new capacity in fast-growing markets (green mobility, energy, sustainable construction, natural consumer solutions).
| Initiative | Detail | Financial/Operational Impact | Timeline |
|---|---|---|---|
| EMILI lithium project | Development of lithium extraction/refining capacity in France | €200m green industry tax credit received; reduces net project cost and improves IRR | Tax credit received Sept 2025; project ramp multi-year |
| End-market expansion | Focus on food & beverage, filtration, pharmaceuticals | Higher-margin specialty sales; supports 3-5% organic profitable growth target | Ongoing (2023-2025 target window) |
| Sustainability & energy | First biodiversity report released; US PPA signed | Reduces carbon exposure, supports ESG positioning and long-term cost stability | Biodiversity report and PPA executed in 2025 |
| Capex allocation | ~40% of capex to fast-growing markets (green mobility, energy, sustainable construction) | Concentrates growth investment where secular demand and pricing power are rising | Capital plan through mid-decade (2023-2025+) |
- Green mobility & energy: development of battery materials and lightweighting minerals tied to EV adoption.
- Sustainable construction: additives and minerals for lower-carbon building materials.
- Natural solutions for consumer goods: tailored minerals for filtration, food processing, and pharmaceutical excipients.

Imerys S.A. (NK.PA) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.